©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 112841
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112841
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112841
Table 2 Comparative overview of the outcome: Anastomotic leakage
| Disbrow et al[10] | Fransgaard et al[11] | Bahl et al[15] | |
| Statin therapy definition | No information available concerning statin medication choice, dose, and duration of use | Statin user is defined as redeeming 2 or more statin prescriptions 1 year before surgery; postoperative continuation period not stated | Short-term statin therapy group: Preoperative statin use (3-7 days) and postoperative duration (14 days); long-term statin therapy group: Ongoing statin therapy |
| Type of surgical data | Colectomy and rectal resection combined and separate | Combined colorectal | Combined colorectal |
| Comorbidities | Diabetes; COPD; ascites/cirrhosis; hypertension; congestive heart failure | NR | NR |
| Results | Unadjusted (statin n/N) 41/1810, PS matched (statin n/N) 35/1786; Unadjusted (non-statin n/N) 56/3196, PS Matched (non-statin n/N) 48/1786 | OR = 1.03, 95%CI: 0.90-1.18, P = 0.80 | Statin (n/N) 8/137; Non-statin (n/N) 3/67 |
- Citation: Mohsin S, Hasan M, Mustafa F, Kumar J, Aleissa M, Bhullar JS, Kumar S. Impact of statin therapy on postoperative outcomes following colorectal cancer surgery: A systematic review. World J Gastrointest Surg 2025; 17(12): 112841
- URL: https://www.wjgnet.com/1948-9366/full/v17/i12/112841.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i12.112841